Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02262910 |
Title | Study of MOR209/ES414 in Metastatic Castration-Resistant Prostate Cancer |
Recruitment | Completed |
Gender | male |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Aptevo Therapeutics |
Indications | |
Therapies | |
Age Groups: | adult | senior | child |
Covered Countries | USA | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
University of California | San Francisco | California | 94143 | United States | Details | |
Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States | Details | |
Central Texas Veterans Health Care System | Temple | Texas | 76504 | United States | Details | |
University of Washington/Seattle Cancer Care Alliance | Seattle | Washington | 98109 | United States | Details | |
St. Vincent's Hospital Sydney | Darlinghurst | New South Wales | 2010 | Australia | Details | |
Monash Medical Centre | Clayton | Victoria | 3168 | Australia | Details | |
Peter MacCallum Cancer Centre | East Melbourne | Victoria | 3002 | Australia | Details |